BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8733577)

  • 1. Modulation of sexual behaviour in the rat by a potent and selective alpha 2-adrenoceptor antagonist, delequamine (RS-15385-197).
    Tallentire D; McRae G; Spedding M; Clark R; Vickery B
    Br J Pharmacol; 1996 May; 118(1):63-72. PubMed ID: 8733577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the anxiogenic agent, RS-30199, with 5-HT1A receptors: modulation of sexual activity in the male rat.
    Spedding M; Newman-Tancredi A; Millan MJ; Dacquet C; Michel AN; Jacoby E; Vickery B; Tallentire D
    Neuropharmacology; 1998 Jun; 37(6):769-80. PubMed ID: 9707291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of idazoxan and 8-OH-DPAT on sexual behaviour and associated ultrasonic vocalizations in the rat.
    Mos J; Van Logten J; Bloetjes K; Olivier B
    Neurosci Biobehav Rev; 1991; 15(4):505-15. PubMed ID: 1686488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of delequamine (RS15385) on female sexual behaviour in the rat.
    Gonzalez MI; Patmore L; Wilson CA
    Eur J Pharmacol; 1996 Sep; 312(1):1-6. PubMed ID: 8891572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A re-evaluation of the role of alpha 2-adrenoceptors in the anxiogenic effects of yohimbine, using the selective antagonist delequamine in the rat.
    Redfern WS; Williams A
    Br J Pharmacol; 1995 Oct; 116(3):2081-9. PubMed ID: 8640349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of central noradrenergic function by RS-15385-197.
    Redfern WS; MacKinnon AC; Brown CM; Martin AB; Kilpatrick AT; Clague RU; Spedding M
    Br J Pharmacol; 1993 Feb; 108(2):526-33. PubMed ID: 8095421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 2-adrenoceptor antagonists and male sexual behavior: I. Mating behavior.
    Smith ER; Lee RL; Schnur SL; Davidson JM
    Physiol Behav; 1987; 41(1):7-14. PubMed ID: 2891151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
    Truitt W; Harrison L; Guptarak J; White S; Hiegel C; Uphouse L
    Brain Res; 2003 Jun; 974(1-2):202-11. PubMed ID: 12742638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential interactions of "prosexual" drugs with 5-hydroxytryptamine1A and alpha 2-adrenergic receptors.
    Kwong LL; Smith ER; Davidson JM; Peroutka SJ
    Behav Neurosci; 1986 Oct; 100(5):664-8. PubMed ID: 2877677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
    Brown CM; MacKinnon AC; Redfern WS; Hicks PE; Kilpatrick AT; Small C; Ramcharan M; Clague RU; Clark RD; MacFarlane CB
    Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuating effects of prior oestradiol benzoate priming on 5-HT-mediated lordosis behavior in rats are dose-dependent.
    Siddiqui A; Shaharyar S
    Acta Physiol Hung; 2007 Sep; 94(3):209-21. PubMed ID: 17853773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moderate role of oxytocin in the pro-ejaculatory effect of the 5-HT1A receptor agonist 8-OH-DPAT.
    de Jong TR; Neumann ID
    J Sex Med; 2015 Jan; 12(1):17-28. PubMed ID: 25359190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of the serotonin1A agonist, 8-OH-DPAT, on masculine and feminine sexual behavior of the ferret.
    Paredes RG; Kica E; Baum MJ
    Psychopharmacology (Berl); 1994 May; 114(4):591-6. PubMed ID: 7855220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-OH-DPAT stimulates gastric acid secretion through a vagal-independent, adrenal-mediated mechanism.
    Gidener S; LePard KJ; Stephens RL
    Eur J Pharmacol; 1995 Sep; 284(1-2):19-24. PubMed ID: 8549624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain differences in the response to the 5-HT1A receptor agonist, 8-OH-DPAT.
    Uphouse L; Maswood S; Jackson A; Brown K; Prullage J; Myers T; Shaheen F
    Pharmacol Biochem Behav; 2002 Jun; 72(3):533-42. PubMed ID: 12175449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN.
    Uphouse L; Caldarola-Pastuszka M; Maswood S; Andrade M; Moore N
    Brain Res; 1994 Feb; 637(1-2):173-80. PubMed ID: 8180795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1 receptor agonists attenuate the naloxone-induced jumping behaviour in morphine-dependent mice.
    Berthold H; Fozard JR; Engel G
    Eur J Pharmacol; 1989 Mar; 162(1):19-27. PubMed ID: 2566495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181.
    Hillegaart V; Ahlenius S
    Br J Pharmacol; 1998 Dec; 125(8):1733-43. PubMed ID: 9886765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are 5-HT receptors or beta-adrenoceptors involved in idazoxan-induced food and water intake?
    Jackson HC; Nutt DJ
    Neuropharmacology; 1992 Nov; 31(11):1081-7. PubMed ID: 1361965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.